No insider purchase over the last 90 days. The latest was filed 15 May 2026.
Headquartered in Basel, Switzerland, Roche Holding AG belongs to the Health Care sector and traces its origins to 1966. Filings by its managers are published through SIX SER. Over the twelve months to 18 October 2026, the company's managers filed 23 filings, from 3 insiders.
Both sides are active: 9 purchases worth €4.8M and 14 sales worth €14.8M, from 2 insiders and 3 insiders respectively. On balance, insiders were net sellers of €10.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 2 senior executives. Biggest ticket of the year: €4.1M, sold and made public on 30 January 2026.
In all, 4 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 15 May 2026, which is 155 days ago. Publication is fast: at least half of the trades appear on SIX SER on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 177 companies tracked on its exchange, the median is 9 filings; at 23 filings, this issuer sits above that mark. Since 2023, the database holds 24 purchases and 28 sales by insiders of the company.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. These figures are compiled from regulatory filings published by SIX SER. They describe what insiders did and are not a recommendation.
Analysts rate Roche Holding AG Buy (bullish), based on 2 analysts. Average price target: CHF 368.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 52 declarations
Roche Holding AG is a Swiss company specializing in pharmaceuticals and diagnostics. It is one of the global leaders in healthcare, providing innovative solutions for the treatment of various diseases.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Basel, Switzerland · Founded: 1966 · 100,920 employees (2021) · Wikipedia article
Source: Wikidata (CC0).